From a technological standpoint, the integration of Bionano's VIA™ software into Revvity's NGS workflow represents a significant advancement. The software's ability to add CNV assessment and streamline workflow interpretation is a notable improvement, potentially increasing the precision and efficiency of genetic screening processes. This can drastically reduce the time required to analyze genetic data and make it more accessible to a broader range of healthcare providers. Moreover, the use of cloud-based data management in this agreement highlights a trend towards more scalable and flexible genomic analysis solutions. The cloud infrastructure not only ensures data security and accessibility but also facilitates large-scale data processing, which is essential for handling the comprehensive datasets generated in newborn sequencing research. On the downside, reliance on cloud solutions does entail potential cybersecurity risks and ensuring data privacy will be paramount.